L. Tarnow et al., Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy, DIABET CARE, 23(1), 2000, pp. 30-33
OBJECTIVE- A familial predisposition was proposed to be a determinant of th
e increased morbidity and mortality from cardiovascular disease in type 1 d
iabetic patients with diabetic nephropathy. The insertion allele of an inse
rtion/deletion polymorphism in the ACE (ACE/ID) gene seems to protect again
st coronary heart disease in nondiabetic and diabetic subjects. The aim of
the present study was to evaluate these hypotheses in parents of a large gr
oup of type 1 diabetic patients with and without diabetic nephropathy.
RESEARCH DESIGN AND METHODS- We investigated cardiovascular morbidity and m
ortality of parents of 163 type 1 diabetic patients with nephropathy and pa
rents of 163 sex- and age-matched normoalbuminuric patients with type 1 dia
betes.
RESULTS- Kaplan-Meier curves showed that total parental mortality was signi
ficantly increased in parents of type 1 diabetic patients with nephropathy
(121 of 244 [similar to 50%]) as compared with parents of normoalbuminuric
type 1 diabetic patients (119 of 269 [similar to 44%]) (P = 0.008 [log-rank
test]) partially due to an increase in cardiovascular deaths (48 of 244 [s
imilar to 20%] vs. 42 of 269 [similar to 16%], P < 0.05). In addition, more
patients with nephropathy, as compared with the normoalbuminuric group, ha
d at least one parent with fatal/nonfatal cardiovascular disease (46% [95%
CI 38-54] vs. 36% [28-44], P = 0.05). Fathers of patients homozygous for th
e I-allele of the ACE/ID polymorphism had significantly less myocardial inf
arction as compared with other genotypes (P = 0.03), regardless of the neph
ropathic state of the offspring.
CONCLUSIONS- Cardiovascular morbidity and early mortality clusters in paren
ts of type 1 diabetic patients with diabetic nephropathy. The ACE/ID polymo
rphism helps explain the increased morbidity from cardiovascular disease.